Article
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.
Clinical pharmacology and therapeutics - 1 May 2014
Martin M A, Hoffman J M, Freimuth R R, Klein T E, Dong B J, Pirmohamed M, Hicks J K, Wilkinson M R, Haas D W, Kroetz D L
Abstract excerpt
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing were originally published in April 2012. We reviewed recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the Supplementary Material...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.